EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+9.23%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.08B
AUM Growth
+$5.08B
(+8.7%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
6.03%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$78M |
| 2 |
Biohaven
BHVN
|
$74.9M |
| 3 |
Doximity
DOCS
|
$57.4M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$55.8M |
| 5 |
DoubleVerify
DV
|
$50.5M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$165M |
| 2 |
Cogent Biosciences
COGT
|
$33.3M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$33.2M |
| 4 |
Duolingo
DUOL
|
$33.1M |
| 5 |
Kura Oncology
KURA
|
$32.8M |
Sector Composition
| 1 | Healthcare | 38.81% |
| 2 | Technology | 25% |
| 3 | Industrials | 15.64% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Utilities | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cheniere Energy
LNG
$53.1B
| $67.2M | 1.32% | 404,882 -2,418 | -0.6% | -$401K |
|
27
Global E Online
GLBE
$5.68B
| $67M | 1.32% | 2,503,371 +150,000 | +6% | +$4.01M |
|
28
Exact Sciences
EXAS
$8.98B
| $60.7M | 1.19% | 1,867,365 +501,765 | +37% | +$16.3M |
|
29
Sprout Social
SPT
$929M
| $60.1M | 1.18% | 990,943 | – | – |
|
|
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $60.1M | 1.18% | 971,200 +901,400 | +1,291% | +$55.8M |
|
31
HubSpot
HUBS
$25.5B
| $58M | 1.14% | 214,865 -1,868 | -0.9% | -$505K |
|
32
MongoDB
MDB
$25.7B
| $57.4M | 1.13% | 289,160 +203,160 | +236% | +$40.3M |
|
33
Aptiv
APTV
$17.3B
| $56.3M | 1.11% | 720,147 +447 | +0.1% | +$35K |
|
34
Crown Castle
CCI
$43.2B
| $54M | 1.06% | 373,912 +24,412 | +7% | +$3.53M |
|
35
Entegris
ENTG
$12.7B
| $53.9M | 1.06% | 649,268 +2,638 | +0.4% | +$219K |
|
|
36
DoubleVerify
DV
$2.66B
| $50.5M | 0.99% | +1,847,144 | New | +$50.5M |
|
37
Celldex Therapeutics
CLDX
$1.47B
| $50.4M | 0.99% | 1,791,800 +346,100 | +24% | +$9.73M |
|
38
D.R. Horton
DHI
$50.5B
| $48.9M | 0.96% | 726,643 -54,857 | -7% | -$3.69M |
|
39
Generac Holdings
GNRC
$10.9B
| $48M | 0.95% | 269,700 | – | – |
|
40
Enphase Energy
ENPH
$4.93B
| $45.2M | 0.89% | 163,000 | – | – |
|
41
Datadog
DDOG
$47.7B
| $45.1M | 0.89% | 507,635 +1,016 | +0.2% | +$90.2K |
|
42
Agilent Technologies
A
$35.7B
| $43.5M | 0.86% | 358,200 | – | – |
|
43
Trex
TREX
$6.61B
| $43.5M | 0.86% | 990,000 | – | – |
|
44
Monolithic Power Systems
MPWR
$40B
| $43.1M | 0.85% | 118,598 +750 | +0.6% | +$273K |
|
|
45
Cogent Biosciences
COGT
$1.69B
| $42.7M | 0.84% | 2,860,892 -2,234,108 | -44% | -$33.3M |
|
46
Collegium Pharmaceutical
COLL
$1.22B
| $42.1M | 0.83% | 2,629,593 | – | – |
|
47
Lam Research
LRCX
$127B
| $41.6M | 0.82% | 113,673 +173 | +0.2% | +$63.3K |
|
48
Flywire
FLYW
$1.61B
| $41.3M | 0.81% | 1,800,367 +1,667,446 | +1,254% | +$38.3M |
|
49
Zentalis Pharmaceuticals
ZNTL
$122M
| $40.3M | 0.79% | 1,861,000 +857,000 | +85% | +$18.6M |
|
50
Brookfield Renewable
BEP
$7.2B
| $38.7M | 0.76% | 1,236,000 | – | – |
|